{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T07:39:59Z","timestamp":1795246799758,"version":"4.10.3"},"reference-count":28,"publisher":"American Association for Cancer Research (AACR)","issue":"8","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Immunotherapies have demonstrated limited clinical efficacy in malignant mesothelioma treatment. We conducted multiplex immunofluorescence analyses on tissue microarrays (n = 3) from patients with malignant pleural mesothelioma (MPM,\u00a0n\u00a0= 88) and malignant peritoneal mesothelioma (MPeM, n = 25). Our study aimed to elucidate spatial distributions of key immune cell populations and their association with lymphocyte activation gene 3 (LAG3), BRCA1-associated protein 1 (BAP1), neurofibromatosis type 2 (NF2), and methylthioadenosine phosphorylase (MTAP), with MTAP serving as a cyclin-dependent kinase inhibitor 2A\/2B (CDKN2A\/B) surrogate marker. Additionally, we examined the relationship between the spatial distribution of major immune cell types and prognosis and clinical characteristics of patients with malignant mesothelioma. We observed a higher degree of interaction between immune cells and tumor cells in MPM compared with MPeM. Notably, within MPM tumors, we detected a significantly increased interaction between tumor cells and CD8+ T cells in tumors with low BAP1 expression compared with those with high BAP1 expression. To support the broader research community, we have developed The Human Spatial Atlas of Malignant Mesothelioma, containing hematoxylin and eosin and multiplex immunofluorescence images with corresponding metadata.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Considering the limited therapeutic options available to patients with malignant mesothelioma, there is substantial translational potential in understanding the correlation between the spatial architecture of the malignant mesothelioma tumor immune microenvironment and tumor biology. Our investigation reveals critical cell\u2013cell interactions that may influence the immune response against malignant mesothelioma tumors, potentially contributing to the differential behaviors observed in MPM and MPeM. These findings represent a valuable resource for the malignant mesothelioma cancer research community.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-23-0524","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T06:09:58Z","timestamp":1720764598000},"page":"2133-2146","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Spatial Landscape of Malignant Pleural and Peritoneal Mesothelioma Tumor Immune Microenvironments"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3812-0473","authenticated-orcid":false,"given":"Xiaojun","family":"Ma","sequence":"first","affiliation":[{"name":"UPMC Hillman Cancer Center, Cancer Biology Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7377-7027","authenticated-orcid":false,"given":"David","family":"Lembersky","sequence":"additional","affiliation":[{"name":"UPMC Hillman Cancer Center, Cancer Biology Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8666-5681","authenticated-orcid":false,"given":"Elena S.","family":"Kim","sequence":"additional","affiliation":[{"name":"UPMC Hillman Cancer Center, Cancer Biology Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 1"},{"name":"Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5998-8074","authenticated-orcid":false,"given":"Michael J.","family":"Becich","sequence":"additional","affiliation":[{"name":"UPMC Hillman Cancer Center, Cancer Biology Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 1"},{"name":"Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1301-5175","authenticated-orcid":false,"given":"Joseph R.","family":"Testa","sequence":"additional","affiliation":[{"name":"Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6433-0207","authenticated-orcid":false,"given":"Tullia C.","family":"Bruno","sequence":"additional","affiliation":[{"name":"UPMC Hillman Cancer Center, Cancer Biology Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 1"},{"name":"Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3175-1777","authenticated-orcid":false,"given":"Hatice U.","family":"Osmanbeyoglu","sequence":"additional","affiliation":[{"name":"UPMC Hillman Cancer Center, Cancer Biology Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 1"},{"name":"Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 2"},{"name":"Department of Bioengineering, University of Pittsburgh School of Engineering, Pittsburgh, Pennsylvania. 5"},{"name":"Department of Biostatistics, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania. 6"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"2025032818101287600_bib1","first-page":"32","article-title":"Peritoneal mesothelioma: a review","volume":"9","author":"Bridda","year":"2007","journal-title":"MedGenMed"},{"key":"2025032818101287600_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2486\/indhealth.45.379","article-title":"Malignant mesothelioma: global incidence and relationship with asbestos","volume":"45","author":"Bianchi","year":"2007","journal-title":"Ind Health"},{"issue":"Suppl 1","key":"2025032818101287600_bib3","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.21037\/tlcr.2019.12.15","article-title":"Peritoneal mesothelioma","volume":"9","author":"Greenbaum","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"2025032818101287600_bib4","doi-asserted-by":"crossref","first-page":"e000669","DOI":"10.1136\/esmoopen-2019-000669","article-title":"How I treat malignant pleural mesothelioma","volume":"4","author":"Viscardi","year":"2020","journal-title":"ESMO Open"},{"key":"2025032818101287600_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.semdp.2006.08.002","article-title":"The pathogenesis of mesothelioma","volume":"23","author":"Carbone","year":"2006","journal-title":"Semin Diagn Pathol"},{"key":"2025032818101287600_bib6","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jtho.2023.03.013","article-title":"Did the ban on asbestos reduce the incidence of mesothelioma?","volume":"18","author":"Carbone","year":"2023","journal-title":"J Thorac Oncol"},{"key":"2025032818101287600_bib7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/1078-0432.CCR-21-1466","article-title":"FDA approval summary: nivolumab in combination with ipilimumab for the treatment of unresectable malignant pleural mesothelioma","volume":"28","author":"Nakajima","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2025032818101287600_bib8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"key":"2025032818101287600_bib9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.annonc.2022.01.074","article-title":"First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743","volume":"33","author":"Peters","year":"2022","journal-title":"Ann Oncol"},{"key":"2025032818101287600_bib10","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov"},{"key":"2025032818101287600_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5858\/arpa.2011-0215-RA","article-title":"Molecular changes in mesothelioma with an impact on prognosis and treatment","volume":"136","author":"Jean","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"2025032818101287600_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"key":"2025032818101287600_bib13","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41467-021-21798-w","article-title":"Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"2025032818101287600_bib14","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1038\/s41416-022-01979-0","article-title":"Genomic landscape of pleural and peritoneal mesothelioma tumours","volume":"127","author":"Hiltbrunner","year":"2022","journal-title":"Br J Cancer"},{"key":"2025032818101287600_bib15","doi-asserted-by":"crossref","first-page":"100938","DOI":"10.1016\/j.xcrm.2023.100938","article-title":"Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma","volume":"4","author":"Nair","year":"2023","journal-title":"Cell Rep Med"},{"key":"2025032818101287600_bib16","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.3390\/cancers14225626","article-title":"Isolated BAP1 genomic alteration in malignant pleural mesothelioma predicts distinct immunogenicity with implications for immunotherapeutic response","volume":"14","author":"Osmanbeyoglu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025032818101287600_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13073-019-0620-3","article-title":"BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma","volume":"11","author":"Shrestha","year":"2019","journal-title":"Genome Med"},{"key":"2025032818101287600_bib18","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1158\/1078-0432.CCR-21-2390","article-title":"Molecular pathways and mechanisms of LAG3 in cancer therapy","volume":"28","author":"Andrews","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2025032818101287600_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00129039-200309000-00011","article-title":"Simple, inexpensive method for automating tissue microarray production provides enhanced microarray reproducibility","volume":"11","author":"Matysiak","year":"2003","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2025032818101287600_bib20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s43018-023-00549-4","article-title":"Publisher Correction: immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment","volume":"4","author":"Onkar","year":"2023","journal-title":"Nat Cancer"},{"key":"2025032818101287600_bib21","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2018.07.010","article-title":"Deep profiling of mouse splenic architecture with CODEX multiplexed imaging","volume":"174","author":"Goltsev","year":"2018","journal-title":"Cell"},{"key":"2025032818101287600_bib22","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cell.2020.10.021","article-title":"Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front","volume":"183","author":"Schurch","year":"2020","journal-title":"Cell"},{"key":"2025032818101287600_bib23","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"2025032818101287600_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41379-019-0310-0","article-title":"MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma","volume":"33","author":"Chapel","year":"2020","journal-title":"Mod Pathol"},{"key":"2025032818101287600_bib25","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1038\/s41598-021-83858-x","article-title":"Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues","volume":"11","author":"Parra","year":"2021","journal-title":"Sci Rep"},{"key":"2025032818101287600_bib26","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/1759-7714.14981","article-title":"High density and proximity of CD8+ T cells to tumor cells are correlated with better response to nivolumab treatment in metastatic pleural mesothelioma","volume":"14","author":"Yin","year":"2023","journal-title":"Thorac Cancer"},{"key":"2025032818101287600_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13073-021-00931-w","article-title":"Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma","volume":"13","author":"Meiller","year":"2021","journal-title":"Genome Med"},{"key":"2025032818101287600_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12967-014-0301-3","article-title":"Evaluation of clonal origin of malignant mesothelioma","volume":"12","author":"Comertpay","year":"2014","journal-title":"J Transl Med"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-23-0524\/3474723\/crc-23-0524.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/8\/2133\/3498368\/crc-23-0524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/8\/2133\/3498368\/crc-23-0524.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T19:26:30Z","timestamp":1743189990000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/8\/2133\/747011\/Spatial-Landscape-of-Malignant-Pleural-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-23-0524","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.26764419","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046068.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046065.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764407","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046083.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764386","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764398","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688737","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688713","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688725","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046062","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046074","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764407.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046080.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764410.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046059","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764413.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764416","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764404","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764383","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764395","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688728","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764422.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688716","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046071","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046083","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046071.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046056","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046068","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046059.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764401","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764419.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764413","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046074.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764392","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764416.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046077.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688719","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046080","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764401.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764377.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688731","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764380","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764404.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046077","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764392.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764389","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764422","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764380.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764383.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764389.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764386.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764398.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764410","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764377","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046062.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046056.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688722","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26764395.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688734","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688710","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27046065","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.09.06.556559","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7405875","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7405875.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}